Summary & Overview
HCPCS J2599: Vasopressin Injection (American Regent), 1 Unit
HCPCS Level II code J2599 designates a one-unit injection of vasopressin (American Regent) that is specified as not therapeutically equivalent to J2598. Nationally, accurate coding for parenteral vasopressin is important for drug inventory management, billing consistency, and clinical documentation, especially in acute care and critical care settings where vasopressin is used for vasodilatory shock, diabetes insipidus, or other vasopressor indications. Clear identification of product-specific HCPCS codes helps payers and providers differentiate formulations and support appropriate reimbursement and utilization review.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on the code’s clinical context, typical service line and sites of service, common modifiers associated with drug administration billing, and where to find additional resources for coding and billing verification. The publication also outlines benchmarking topics and policy considerations relevant to clinicians, coders, and revenue cycle teams, including unit reporting, product equivalency notes, and payer coverage variability. Data not available in the input are indicated where applicable.
Billing Code Overview
HCPCS Level II code J2599 represents an injection of vasopressin (American Regent), billed per 1 unit, and noted as not therapeutically equivalent to J2598. The description indicates a single-dose parenteral medication intended for clinical use where vasopressin is indicated.
Service Type: Injection (parenteral drug administration)
Typical Site of Service: Inpatient hospital or outpatient clinic settings where parenteral vasopressin administration is provided, including emergency departments and critical care units.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult admitted to an acute care hospital for hypotensive shock unresponsive to initial fluid resuscitation and first-line vasopressors. The treating team orders vasopressin (American Regent) as an adjunct vasopressor infusion or intermittent injection to support blood pressure in distributive or septic shock, or in some cases to treat vasodilatory shock after cardiopulmonary bypass. The medication is dispensed from the hospital pharmacy and administered by an ICU nurse or emergency department nurse. Documentation includes indication (e.g., septic shock), dose units administered (1 unit increments per billing description), route (intravenous), start and stop times for infusion or time of bolus, patient response (blood pressure, vasopressor requirements), and any adverse effects (ischemia, hyponatremia). Billing uses HCPCS Level II code J2599 with appropriate modifiers to reflect service circumstances, and the encounter is coded using the admitting and principal ICD-10 diagnoses reflecting shock or other underlying causes.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Unspecified modifier (neutral) | Rarely used; use when no specific modifier applies and payer requires a placeholder |